Acute Porphyria Drug Database

J05AB14 - Valganciclovir
Not porphyrinogenic
NP

Rationale
Prodrug converted by intestinal and hepatic esterases to ganciclovir, which is not further metabolised.
Chemical description
(To be edited, initial data ST OCT 04) L-valinate ester of the antiviral ganciclovir used to prevent CMV-infection in CMV-negative patients receiving organ transpalantate from CMV positive donor. Rapidly and completely metabolized by intestinal and hepatic esterases to ganciclovir.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes J05A / J05AB or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙